Back to 
FIL Ltd
FIL Ltd
HALO
6 quarters
Position history for FIL Ltd's holdings in Halozyme Therapeutics, Inc.
No. FIL exited its HALO (Halozyme Therapeutics) position in Q4 2023. Its Q3 2023 13F listed 39,161 shares worth $1.5M. FIL first reported HALO in Q3 2022 and held it in 5 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$39.6M
Total Shares Change
-1M
Quarter-by-Quarter History
Other major holders of HALO: BlackRock, Inc., BlackRock Finance, Inc.